

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.88190458 |
| 2 | vocalization behavior (GO:0071625) | 5.62067822 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.40692871 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34481318 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.32761521 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19750296 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.17249103 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.15471791 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05671587 |
| 10 | synaptic vesicle maturation (GO:0016188) | 5.04760101 |
| 11 | actin-myosin filament sliding (GO:0033275) | 5.02538166 |
| 12 | muscle filament sliding (GO:0030049) | 5.02538166 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.92646535 |
| 14 | skeletal muscle contraction (GO:0003009) | 4.82356684 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.80276155 |
| 16 | glutamate secretion (GO:0014047) | 4.75514548 |
| 17 | protein localization to synapse (GO:0035418) | 4.70343005 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.67651695 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.57617867 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 4.52645184 |
| 21 | exploration behavior (GO:0035640) | 4.50608303 |
| 22 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.43944457 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.40436073 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31177053 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.29127372 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.25562249 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.25175163 |
| 28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.20515188 |
| 29 | actin-mediated cell contraction (GO:0070252) | 4.20262112 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.15931103 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 4.14435489 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 4.13479832 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.08316090 |
| 34 | neuron recognition (GO:0008038) | 3.98522655 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97786319 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.95821830 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 3.92132209 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.90884232 |
| 39 | long-term memory (GO:0007616) | 3.90326461 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.82496523 |
| 41 | sodium ion export (GO:0071436) | 3.79634965 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.78573411 |
| 43 | proline transport (GO:0015824) | 3.77643263 |
| 44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.76695755 |
| 45 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.74733341 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.68227076 |
| 47 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.65878233 |
| 48 | neurotransmitter transport (GO:0006836) | 3.63401864 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62697086 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.61674223 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61432554 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.58601682 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.57598141 |
| 54 | axonal fasciculation (GO:0007413) | 3.57381966 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54351032 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.53914919 |
| 57 | skeletal muscle fiber development (GO:0048741) | 3.51460278 |
| 58 | striated muscle contraction (GO:0006941) | 3.51235776 |
| 59 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.49288907 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.47031646 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.45612820 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43322222 |
| 63 | regulation of female receptivity (GO:0045924) | 3.43012029 |
| 64 | regulation of vesicle fusion (GO:0031338) | 3.42566311 |
| 65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38950444 |
| 66 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.35538682 |
| 67 | myofibril assembly (GO:0030239) | 3.35284319 |
| 68 | myotube cell development (GO:0014904) | 3.34440512 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.33225992 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33214979 |
| 71 | negative regulation of norepinephrine secretion (GO:0010700) | 3.32762368 |
| 72 | postsynaptic membrane organization (GO:0001941) | 3.32299895 |
| 73 | innervation (GO:0060384) | 3.31377428 |
| 74 | response to histamine (GO:0034776) | 3.31044102 |
| 75 | activation of protein kinase A activity (GO:0034199) | 3.29534820 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.23882482 |
| 77 | negative regulation of muscle contraction (GO:0045932) | 3.22619900 |
| 78 | actin filament-based movement (GO:0030048) | 3.18708946 |
| 79 | negative regulation of protein localization to cell surface (GO:2000009) | 3.18496597 |
| 80 | behavioral fear response (GO:0001662) | 3.18017834 |
| 81 | behavioral defense response (GO:0002209) | 3.18017834 |
| 82 | regulation of relaxation of muscle (GO:1901077) | 3.17147831 |
| 83 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.16773883 |
| 84 | cell communication by electrical coupling (GO:0010644) | 3.14208622 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.13515103 |
| 86 | mating behavior (GO:0007617) | 3.12627223 |
| 87 | membrane depolarization (GO:0051899) | 3.12594000 |
| 88 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.11054271 |
| 89 | learning (GO:0007612) | 3.10958296 |
| 90 | glycogen catabolic process (GO:0005980) | 3.08427476 |
| 91 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.07844518 |
| 92 | synapse assembly (GO:0007416) | 3.07189293 |
| 93 | muscle contraction (GO:0006936) | 3.06864519 |
| 94 | creatine metabolic process (GO:0006600) | 3.06480259 |
| 95 | membrane hyperpolarization (GO:0060081) | 3.05749711 |
| 96 | positive regulation of dendritic spine development (GO:0060999) | 3.04551910 |
| 97 | dendritic spine organization (GO:0097061) | 3.03977689 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03778655 |
| 99 | neuromuscular process controlling balance (GO:0050885) | 3.03233876 |
| 100 | presynaptic membrane organization (GO:0097090) | 3.03044877 |
| 101 | startle response (GO:0001964) | 3.02766266 |
| 102 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.02529793 |
| 103 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02082973 |
| 104 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.01770692 |
| 105 | membrane depolarization during action potential (GO:0086010) | 3.01495578 |
| 106 | relaxation of muscle (GO:0090075) | 3.01308934 |
| 107 | regulation of dendritic spine development (GO:0060998) | 2.99121263 |
| 108 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.98992786 |
| 109 | fear response (GO:0042596) | 2.98730898 |
| 110 | long term synaptic depression (GO:0060292) | 2.98114305 |
| 111 | cellular sodium ion homeostasis (GO:0006883) | 2.97564764 |
| 112 | skeletal muscle tissue regeneration (GO:0043403) | 2.97541030 |
| 113 | regulation of synapse maturation (GO:0090128) | 2.97155806 |
| 114 | social behavior (GO:0035176) | 2.96657395 |
| 115 | intraspecies interaction between organisms (GO:0051703) | 2.96657395 |
| 116 | neuromuscular process controlling posture (GO:0050884) | 2.96423926 |
| 117 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.95723493 |
| 118 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.95354605 |
| 119 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.95354605 |
| 120 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.94469560 |
| 121 | synaptic transmission (GO:0007268) | 2.93618424 |
| 122 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93441908 |
| 123 | regulation of synaptic transmission (GO:0050804) | 2.92586498 |
| 124 | dendrite morphogenesis (GO:0048813) | 2.91540813 |
| 125 | glucan catabolic process (GO:0009251) | 2.91466797 |
| 126 | glycine transport (GO:0015816) | 2.90758386 |
| 127 | vesicle transport along microtubule (GO:0047496) | 2.90211817 |
| 128 | regulation of neurotransmitter transport (GO:0051588) | 2.89658719 |
| 129 | positive regulation of synaptic transmission (GO:0050806) | 2.88196823 |
| 130 | synapse organization (GO:0050808) | 2.87158968 |
| 131 | cerebellar granule cell differentiation (GO:0021707) | 2.87107843 |
| 132 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86989664 |
| 133 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86989664 |
| 134 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.86460600 |
| 135 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.83370277 |
| 136 | regulation of platelet aggregation (GO:0090330) | 2.82511803 |
| 137 | skeletal muscle adaptation (GO:0043501) | 2.82209850 |
| 138 | muscle system process (GO:0003012) | 2.81245959 |
| 139 | female mating behavior (GO:0060180) | 2.78358424 |
| 140 | cGMP-mediated signaling (GO:0019934) | 2.74142807 |
| 141 | cellular polysaccharide catabolic process (GO:0044247) | 2.71633556 |
| 142 | negative regulation of heart contraction (GO:0045822) | 2.70264769 |
| 143 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.67550206 |
| 144 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.67124338 |
| 145 | cardiac muscle contraction (GO:0060048) | 2.62410321 |
| 146 | sarcomere organization (GO:0045214) | 2.60930558 |
| 147 | cellular response to epinephrine stimulus (GO:0071872) | 2.59902684 |
| 148 | potassium ion import (GO:0010107) | 2.55883694 |
| 149 | muscle fiber development (GO:0048747) | 2.55316698 |
| 150 | negative regulation of platelet activation (GO:0010544) | 2.54034341 |
| 151 | cellular response to monoamine stimulus (GO:0071868) | 2.53410194 |
| 152 | cellular response to catecholamine stimulus (GO:0071870) | 2.53410194 |
| 153 | regulation of lipoprotein metabolic process (GO:0050746) | 2.53245246 |
| 154 | response to muscle activity (GO:0014850) | 2.52194371 |
| 155 | cardiac myofibril assembly (GO:0055003) | 2.51736128 |
| 156 | negative regulation of blood circulation (GO:1903523) | 2.51463634 |
| 157 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.50470191 |
| 158 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.50164664 |
| 159 | neurotransmitter uptake (GO:0001504) | 2.49904835 |
| 160 | striated muscle adaptation (GO:0014888) | 2.44748380 |
| 161 | polysaccharide catabolic process (GO:0000272) | 2.44660806 |
| 162 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.44372388 |
| 163 | myelination in peripheral nervous system (GO:0022011) | 2.41271002 |
| 164 | peripheral nervous system axon ensheathment (GO:0032292) | 2.41271002 |
| 165 | neuromuscular synaptic transmission (GO:0007274) | 2.40491578 |
| 166 | negative regulation of catecholamine secretion (GO:0033604) | 2.40490364 |
| 167 | plasma membrane repair (GO:0001778) | 2.40356906 |
| 168 | response to inactivity (GO:0014854) | 2.39775025 |
| 169 | cardiac muscle hypertrophy (GO:0003300) | 2.39344324 |
| 170 | adenosine receptor signaling pathway (GO:0001973) | 2.38040778 |
| 171 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.37546759 |
| 172 | regulation of protein localization to cell surface (GO:2000008) | 2.36947502 |
| 173 | myotube differentiation (GO:0014902) | 2.36585539 |
| 174 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.36430645 |
| 175 | regulation of platelet activation (GO:0010543) | 2.35187006 |
| 176 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.34233220 |
| 177 | regulation of actin filament-based movement (GO:1903115) | 2.31321493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.98636653 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72151611 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16323130 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15320302 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14712822 |
| 6 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.96294946 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77487769 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77487769 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69527308 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67633864 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62973696 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57869618 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55012388 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50386662 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49573863 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48164044 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.45359933 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38527503 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33056798 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25634894 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.24694843 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.23745471 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22740314 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18786194 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07583148 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06758896 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94603713 |
| 28 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.94313683 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94002864 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92027674 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91719948 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89302290 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88775722 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83106874 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75734138 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70882484 |
| 37 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69299768 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64347352 |
| 39 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58516748 |
| 40 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50283185 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50171906 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49919187 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49131968 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45622176 |
| 45 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.44233668 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43821077 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38479031 |
| 48 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37800963 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34743611 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33979866 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32773365 |
| 52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32344655 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32180092 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32004761 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30752798 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30717085 |
| 57 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30391958 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30344491 |
| 59 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29986797 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29187240 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28630218 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28191564 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27708445 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24260455 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24238020 |
| 66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23679994 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21515994 |
| 68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19477306 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.18289727 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17436969 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17322844 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15521557 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15330772 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14792249 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13645785 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11514270 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10731212 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10263786 |
| 79 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09620848 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08586133 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08482971 |
| 82 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07888913 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07174843 |
| 84 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06969644 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06766686 |
| 86 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06530059 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05938893 |
| 88 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05704068 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04085015 |
| 90 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03197751 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03091596 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02426531 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01509226 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01370078 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00978900 |
| 96 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00567388 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00430285 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00421036 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00421036 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99885662 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99419114 |
| 102 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98872045 |
| 103 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98366396 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98103957 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96864984 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96510066 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96274011 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95463170 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94999215 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93925073 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.93654943 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93335548 |
| 113 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92803205 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92715325 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92241604 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91130627 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90233428 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89977284 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89941767 |
| 120 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89682439 |
| 121 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89576799 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89021127 |
| 123 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89021127 |
| 124 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88618471 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87782900 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87669297 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86929463 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86526855 |
| 129 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86502504 |
| 130 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86405837 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85045995 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85045995 |
| 133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84648909 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84072012 |
| 135 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82665430 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81556164 |
| 137 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81228964 |
| 138 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.80688752 |
| 139 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78893441 |
| 140 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77379090 |
| 141 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74482767 |
| 142 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.72359400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.25603874 |
| 2 | MP0003880_abnormal_central_pattern | 5.45126886 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.16388532 |
| 4 | MP0009745_abnormal_behavioral_response | 3.45088617 |
| 5 | MP0004270_analgesia | 3.38535171 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.35787077 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.28461960 |
| 8 | MP0002064_seizures | 3.21164835 |
| 9 | MP0000749_muscle_degeneration | 3.19307591 |
| 10 | MP0009046_muscle_twitch | 3.09073051 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.89964157 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.80340264 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.76537017 |
| 14 | MP0003646_muscle_fatigue | 2.71844950 |
| 15 | MP0002272_abnormal_nervous_system | 2.70669600 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.62277748 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.55217415 |
| 18 | MP0001486_abnormal_startle_reflex | 2.54715221 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.48586749 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.41156894 |
| 21 | MP0002736_abnormal_nociception_after | 2.24877020 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.24720834 |
| 23 | MP0008004_abnormal_stomach_pH | 2.17951409 |
| 24 | MP0005620_abnormal_muscle_contractility | 2.16388772 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.12718372 |
| 26 | MP0003329_amyloid_beta_deposits | 2.08532081 |
| 27 | MP0000759_abnormal_skeletal_muscle | 2.04249064 |
| 28 | MP0002067_abnormal_sensory_capabilities | 2.00725301 |
| 29 | MP0002822_catalepsy | 1.99755743 |
| 30 | MP0000747_muscle_weakness | 1.97658830 |
| 31 | MP0004087_abnormal_muscle_fiber | 1.96190900 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.95230610 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.93005049 |
| 34 | MP0001970_abnormal_pain_threshold | 1.88591962 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.88587414 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.87888158 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.85330483 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.83205945 |
| 39 | MP0005369_muscle_phenotype | 1.82249902 |
| 40 | MP0002184_abnormal_innervation | 1.81731944 |
| 41 | MP0000778_abnormal_nervous_system | 1.75148774 |
| 42 | MP0008569_lethality_at_weaning | 1.72988352 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.70811159 |
| 44 | MP0004924_abnormal_behavior | 1.70811159 |
| 45 | MP0002557_abnormal_social/conspecific_i | 1.68066722 |
| 46 | MP0002108_abnormal_muscle_morphology | 1.65094791 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.63838999 |
| 48 | MP0001984_abnormal_olfaction | 1.60988538 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.55909422 |
| 50 | MP0004858_abnormal_nervous_system | 1.52420017 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.52388519 |
| 52 | MP0005670_abnormal_white_adipose | 1.52008924 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.51770785 |
| 54 | MP0001529_abnormal_vocalization | 1.51416628 |
| 55 | MP0006138_congestive_heart_failure | 1.49132493 |
| 56 | MP0004885_abnormal_endolymph | 1.48945155 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.45375645 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.45079372 |
| 59 | MP0000955_abnormal_spinal_cord | 1.43810032 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.40865291 |
| 61 | MP0003879_abnormal_hair_cell | 1.40458821 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.39989220 |
| 63 | MP0003787_abnormal_imprinting | 1.37360987 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.36352040 |
| 65 | MP0004142_abnormal_muscle_tone | 1.34037239 |
| 66 | MP0001905_abnormal_dopamine_level | 1.33741682 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.32352030 |
| 68 | MP0003633_abnormal_nervous_system | 1.31285785 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.30638543 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.29338611 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 1.25229919 |
| 72 | MP0002269_muscular_atrophy | 1.23339312 |
| 73 | MP0001188_hyperpigmentation | 1.19158683 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 1.18831424 |
| 75 | MP0003122_maternal_imprinting | 1.17050957 |
| 76 | MP0002971_abnormal_brown_adipose | 1.16696587 |
| 77 | MP0000751_myopathy | 1.15711439 |
| 78 | MP0000230_abnormal_systemic_arterial | 1.13648872 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.12855110 |
| 80 | MP0001544_abnormal_cardiovascular_syste | 1.12708501 |
| 81 | MP0005385_cardiovascular_system_phenoty | 1.12708501 |
| 82 | MP0000579_abnormal_nail_morphology | 1.11818319 |
| 83 | MP0003631_nervous_system_phenotype | 1.11736360 |
| 84 | MP0004742_abnormal_vestibular_system | 1.10807300 |
| 85 | MP0002229_neurodegeneration | 1.09242356 |
| 86 | MP0005083_abnormal_biliary_tract | 1.08801095 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 1.08075289 |
| 88 | MP0003638_abnormal_response/metabolism_ | 1.06641265 |
| 89 | MP0000013_abnormal_adipose_tissue | 1.06149600 |
| 90 | MP0010386_abnormal_urinary_bladder | 1.04770389 |
| 91 | MP0002152_abnormal_brain_morphology | 1.04738611 |
| 92 | MP0005535_abnormal_body_temperature | 0.99910276 |
| 93 | MP0008775_abnormal_heart_ventricle | 0.99681650 |
| 94 | MP0005275_abnormal_skin_tensile | 0.99317202 |
| 95 | MP0002090_abnormal_vision | 0.98675526 |
| 96 | MP0000604_amyloidosis | 0.95749492 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.94626907 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.94288365 |
| 99 | MP0008872_abnormal_physiological_respon | 0.93903119 |
| 100 | MP0000733_abnormal_muscle_development | 0.93703893 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.93142343 |
| 102 | MP0005330_cardiomyopathy | 0.93080514 |
| 103 | MP0003690_abnormal_glial_cell | 0.92348900 |
| 104 | MP0003634_abnormal_glial_cell | 0.90011967 |
| 105 | MP0002796_impaired_skin_barrier | 0.89868112 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.89823130 |
| 107 | MP0006072_abnormal_retinal_apoptosis | 0.89613383 |
| 108 | MP0001177_atelectasis | 0.88294477 |
| 109 | MP0008874_decreased_physiological_sensi | 0.87719275 |
| 110 | MP0003724_increased_susceptibility_to | 0.86541356 |
| 111 | MP0000920_abnormal_myelination | 0.85757019 |
| 112 | MP0004484_altered_response_of | 0.84444380 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.84250374 |
| 114 | MP0004085_abnormal_heartbeat | 0.81585371 |
| 115 | MP0003632_abnormal_nervous_system | 0.80483503 |
| 116 | MP0003828_pulmonary_edema | 0.80177080 |
| 117 | MP0002127_abnormal_cardiovascular_syste | 0.79691359 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.77546853 |
| 119 | MP0005451_abnormal_body_composition | 0.75836658 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.75412830 |
| 121 | MP0003075_altered_response_to | 0.74216533 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.73002989 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.70489655 |
| 124 | MP0002638_abnormal_pupillary_reflex | 0.70401671 |
| 125 | MP0004233_abnormal_muscle_weight | 0.69054103 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.68772996 |
| 127 | MP0005409_darkened_coat_color | 0.68579390 |
| 128 | MP0000343_altered_response_to | 0.67804069 |
| 129 | MP0000631_abnormal_neuroendocrine_gland | 0.67704965 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.67228842 |
| 131 | MP0005499_abnormal_olfactory_system | 0.67228842 |
| 132 | MP0003011_delayed_dark_adaptation | 0.67178504 |
| 133 | MP0001664_abnormal_digestion | 0.67018563 |
| 134 | MP0003045_fibrosis | 0.64248655 |
| 135 | MP0005253_abnormal_eye_physiology | 0.64013037 |
| 136 | MP0005187_abnormal_penis_morphology | 0.63995616 |
| 137 | MP0010329_abnormal_lipoprotein_level | 0.62241452 |
| 138 | MP0001485_abnormal_pinna_reflex | 0.61363838 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.61161645 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.59879101 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.58763283 |
| 142 | MP0004130_abnormal_muscle_cell | 0.56393338 |
| 143 | MP0000026_abnormal_inner_ear | 0.55748629 |
| 144 | MP0003283_abnormal_digestive_organ | 0.54932040 |
| 145 | MP0001943_abnormal_respiration | 0.54075647 |
| 146 | MP0010234_abnormal_vibrissa_follicle | 0.52787776 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.52334565 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.52205857 |
| 149 | MP0004510_myositis | 0.50905900 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.50363024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.12449317 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.74000417 |
| 3 | Nemaline bodies (HP:0003798) | 7.60012517 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.36312011 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.17499272 |
| 6 | Myokymia (HP:0002411) | 5.98279461 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.92139845 |
| 8 | Focal seizures (HP:0007359) | 5.81274830 |
| 9 | Visual hallucinations (HP:0002367) | 5.64394737 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.95403957 |
| 11 | Atonic seizures (HP:0010819) | 4.80501053 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.78067881 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.75508828 |
| 14 | Distal arthrogryposis (HP:0005684) | 4.75073804 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 4.58807905 |
| 16 | Febrile seizures (HP:0002373) | 4.53956394 |
| 17 | Muscle fiber splitting (HP:0003555) | 4.52576456 |
| 18 | Absence seizures (HP:0002121) | 4.51474949 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.34045091 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.12859270 |
| 21 | Dialeptic seizures (HP:0011146) | 4.11313167 |
| 22 | Prolonged bleeding time (HP:0003010) | 4.07334139 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 4.05250216 |
| 24 | Round ear (HP:0100830) | 4.01725939 |
| 25 | Menorrhagia (HP:0000132) | 3.87995763 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 3.86674495 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.84544194 |
| 28 | Myopathic facies (HP:0002058) | 3.84501043 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 3.83546959 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.74350382 |
| 31 | Action tremor (HP:0002345) | 3.72168372 |
| 32 | Increased mean platelet volume (HP:0011877) | 3.70418899 |
| 33 | Difficulty running (HP:0009046) | 3.70307458 |
| 34 | Hyperventilation (HP:0002883) | 3.65529206 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.61389712 |
| 36 | Neurofibrillary tangles (HP:0002185) | 3.56751364 |
| 37 | Broad-based gait (HP:0002136) | 3.55242164 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 3.52753364 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.46194379 |
| 40 | Dysdiadochokinesis (HP:0002075) | 3.42298084 |
| 41 | Abnormality of the calf musculature (HP:0001430) | 3.39794039 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 3.35308106 |
| 43 | Abnormal platelet volume (HP:0011876) | 3.34216038 |
| 44 | Neck muscle weakness (HP:0000467) | 3.25521668 |
| 45 | Dysmetria (HP:0001310) | 3.25099547 |
| 46 | Rimmed vacuoles (HP:0003805) | 3.17258622 |
| 47 | Frequent falls (HP:0002359) | 3.14858161 |
| 48 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.13870160 |
| 49 | Subaortic stenosis (HP:0001682) | 3.13870160 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 3.13294137 |
| 51 | Mutism (HP:0002300) | 3.11767622 |
| 52 | Truncal ataxia (HP:0002078) | 3.10059501 |
| 53 | Depression (HP:0000716) | 3.08311999 |
| 54 | Amblyopia (HP:0000646) | 3.02687472 |
| 55 | Calcaneovalgus deformity (HP:0001848) | 3.02352562 |
| 56 | Anxiety (HP:0000739) | 3.01111638 |
| 57 | Sudden death (HP:0001699) | 2.99454031 |
| 58 | Hemiparesis (HP:0001269) | 2.97529202 |
| 59 | Diplopia (HP:0000651) | 2.97312539 |
| 60 | Abnormality of binocular vision (HP:0011514) | 2.97312539 |
| 61 | Poor eye contact (HP:0000817) | 2.96632598 |
| 62 | Petechiae (HP:0000967) | 2.95844713 |
| 63 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.94737973 |
| 64 | Excessive salivation (HP:0003781) | 2.94525277 |
| 65 | Drooling (HP:0002307) | 2.94525277 |
| 66 | Abnormal eating behavior (HP:0100738) | 2.93683317 |
| 67 | Progressive inability to walk (HP:0002505) | 2.93422817 |
| 68 | Bundle branch block (HP:0011710) | 2.88168673 |
| 69 | Increased connective tissue (HP:0009025) | 2.86233320 |
| 70 | Purpura (HP:0000979) | 2.86030895 |
| 71 | Myoglobinuria (HP:0002913) | 2.85926241 |
| 72 | Absent phalangeal crease (HP:0006109) | 2.85440419 |
| 73 | Abnormal social behavior (HP:0012433) | 2.80237415 |
| 74 | Impaired social interactions (HP:0000735) | 2.80237415 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.78732696 |
| 76 | Genetic anticipation (HP:0003743) | 2.77506413 |
| 77 | EMG: neuropathic changes (HP:0003445) | 2.76331484 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.75156763 |
| 79 | Postural instability (HP:0002172) | 2.74103638 |
| 80 | Ankle clonus (HP:0011448) | 2.73990689 |
| 81 | Papilledema (HP:0001085) | 2.63911762 |
| 82 | Rhabdomyolysis (HP:0003201) | 2.63031780 |
| 83 | Areflexia of lower limbs (HP:0002522) | 2.59491887 |
| 84 | Myotonia (HP:0002486) | 2.55178955 |
| 85 | Deformed tarsal bones (HP:0008119) | 2.54294165 |
| 86 | Hemiplegia (HP:0002301) | 2.53108148 |
| 87 | Scanning speech (HP:0002168) | 2.52974850 |
| 88 | Absent speech (HP:0001344) | 2.50085753 |
| 89 | Intention tremor (HP:0002080) | 2.47789475 |
| 90 | Epileptiform EEG discharges (HP:0011182) | 2.47670211 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.47490502 |
| 92 | Obstructive sleep apnea (HP:0002870) | 2.47157232 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.46912258 |
| 94 | Bradykinesia (HP:0002067) | 2.42072134 |
| 95 | Scapular winging (HP:0003691) | 2.41330822 |
| 96 | Bulbar palsy (HP:0001283) | 2.39300270 |
| 97 | Impaired smooth pursuit (HP:0007772) | 2.37827732 |
| 98 | Muscle stiffness (HP:0003552) | 2.35291366 |
| 99 | Polyphagia (HP:0002591) | 2.35264389 |
| 100 | Abnormal finger flexion creases (HP:0006143) | 2.33676606 |
| 101 | Malignant hyperthermia (HP:0002047) | 2.32479173 |
| 102 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32457686 |
| 103 | Termporal pattern (HP:0011008) | 2.31770206 |
| 104 | Insidious onset (HP:0003587) | 2.31770206 |
| 105 | Spinal rigidity (HP:0003306) | 2.31014003 |
| 106 | Akinesia (HP:0002304) | 2.30561416 |
| 107 | Abnormality of the corticospinal tract (HP:0002492) | 2.29263947 |
| 108 | Gowers sign (HP:0003391) | 2.27444219 |
| 109 | Spastic gait (HP:0002064) | 2.27252867 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 2.26171942 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 2.24165627 |
| 112 | Urinary urgency (HP:0000012) | 2.23355719 |
| 113 | Status epilepticus (HP:0002133) | 2.20948445 |
| 114 | Abnormality of the lower motor neuron (HP:0002366) | 2.20244592 |
| 115 | Epistaxis (HP:0000421) | 2.20230822 |
| 116 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16737305 |
| 117 | Abnormality of the foot musculature (HP:0001436) | 2.16120409 |
| 118 | Limb dystonia (HP:0002451) | 2.15799219 |
| 119 | Torticollis (HP:0000473) | 2.15263267 |
| 120 | Fetal akinesia sequence (HP:0001989) | 2.15130251 |
| 121 | Stereotypic behavior (HP:0000733) | 2.14282420 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12675114 |
| 123 | Hypsarrhythmia (HP:0002521) | 2.12338116 |
| 124 | Inability to walk (HP:0002540) | 2.12098854 |
| 125 | Focal dystonia (HP:0004373) | 2.11907929 |
| 126 | Delusions (HP:0000746) | 2.11718852 |
| 127 | Lower limb muscle weakness (HP:0007340) | 2.08480907 |
| 128 | Pheochromocytoma (HP:0002666) | 2.08198568 |
| 129 | Megalencephaly (HP:0001355) | 2.07998639 |
| 130 | Ventricular fibrillation (HP:0001663) | 2.06807504 |
| 131 | Psychosis (HP:0000709) | 2.06124315 |
| 132 | Neuronal loss in central nervous system (HP:0002529) | 2.05788762 |
| 133 | Rapidly progressive (HP:0003678) | 2.05120664 |
| 134 | Weak cry (HP:0001612) | 2.01923699 |
| 135 | Hyperlipoproteinemia (HP:0010980) | 2.01530258 |
| 136 | Abnormality of salivation (HP:0100755) | 2.00221019 |
| 137 | Oligomenorrhea (HP:0000876) | 1.99561871 |
| 138 | Heart block (HP:0012722) | 1.98355226 |
| 139 | Generalized muscle weakness (HP:0003324) | 1.98350039 |
| 140 | Slender build (HP:0001533) | 1.97855058 |
| 141 | Gait ataxia (HP:0002066) | 1.97188828 |
| 142 | Dysmetric saccades (HP:0000641) | 1.96064517 |
| 143 | Gingival bleeding (HP:0000225) | 1.95805500 |
| 144 | Retinal dysplasia (HP:0007973) | 1.95643091 |
| 145 | Amyotrophic lateral sclerosis (HP:0007354) | 1.92544427 |
| 146 | Impaired vibratory sensation (HP:0002495) | 1.91716936 |
| 147 | Central scotoma (HP:0000603) | 1.91588272 |
| 148 | Agitation (HP:0000713) | 1.91345321 |
| 149 | Ventricular arrhythmia (HP:0004308) | 1.90824617 |
| 150 | Abnormal atrioventricular conduction (HP:0005150) | 1.90215262 |
| 151 | Neuroendocrine neoplasm (HP:0100634) | 1.88925044 |
| 152 | Hyperkalemia (HP:0002153) | 1.87818067 |
| 153 | Back pain (HP:0003418) | 1.86990711 |
| 154 | Hypoventilation (HP:0002791) | 1.86421150 |
| 155 | Craniofacial dystonia (HP:0012179) | 1.83092113 |
| 156 | Blue irides (HP:0000635) | 1.82267430 |
| 157 | Hyperthyroidism (HP:0000836) | 1.81377399 |
| 158 | Ventricular tachycardia (HP:0004756) | 1.80650446 |
| 159 | Incomplete penetrance (HP:0003829) | 1.79646052 |
| 160 | Inappropriate behavior (HP:0000719) | 1.77770328 |
| 161 | Rigidity (HP:0002063) | 1.76486605 |
| 162 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.76370762 |
| 163 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.76370762 |
| 164 | Difficulty climbing stairs (HP:0003551) | 1.76121695 |
| 165 | Thickened helices (HP:0000391) | 1.76028907 |
| 166 | Dilated cardiomyopathy (HP:0001644) | 1.75799987 |
| 167 | Aortic aneurysm (HP:0004942) | 1.75758947 |
| 168 | Waddling gait (HP:0002515) | 1.75548321 |
| 169 | Abnormality of macular pigmentation (HP:0008002) | 1.74191927 |
| 170 | Type II lissencephaly (HP:0007260) | 1.73971232 |
| 171 | Paralysis (HP:0003470) | 1.73929692 |
| 172 | Steppage gait (HP:0003376) | 1.73452909 |
| 173 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73288756 |
| 174 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73288756 |
| 175 | Aplasia involving bones of the extremities (HP:0009825) | 1.73288756 |
| 176 | Abnormality of the neuromuscular junction (HP:0003398) | 1.71932201 |
| 177 | Fatigable weakness (HP:0003473) | 1.71932201 |
| 178 | Syncope (HP:0001279) | 1.71799250 |
| 179 | Protruding tongue (HP:0010808) | 1.71596796 |
| 180 | Hypercortisolism (HP:0001578) | 1.71103910 |
| 181 | Clumsiness (HP:0002312) | 1.70618096 |
| 182 | Hip contracture (HP:0003273) | 1.69785424 |
| 183 | Nonprogressive disorder (HP:0003680) | 1.67010782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.75018280 |
| 2 | NTRK3 | 4.50362803 |
| 3 | EPHA4 | 4.24692030 |
| 4 | MAP3K9 | 3.67197407 |
| 5 | TTN | 3.29619111 |
| 6 | MAP3K4 | 3.05958890 |
| 7 | MINK1 | 2.70861966 |
| 8 | RIPK4 | 2.65432126 |
| 9 | MARK1 | 2.54792098 |
| 10 | TRIB3 | 2.52116099 |
| 11 | MAP2K7 | 2.46010901 |
| 12 | MAP3K12 | 2.32998809 |
| 13 | PNCK | 2.17642451 |
| 14 | MAPKAPK3 | 2.17249933 |
| 15 | NTRK2 | 2.13040194 |
| 16 | PAK6 | 2.05336522 |
| 17 | KSR2 | 2.02313428 |
| 18 | NTRK1 | 2.02004940 |
| 19 | MAP2K4 | 2.01678394 |
| 20 | CASK | 1.97201266 |
| 21 | DAPK2 | 1.91953532 |
| 22 | MYLK | 1.75036977 |
| 23 | PLK2 | 1.67898120 |
| 24 | PIK3CG | 1.66133481 |
| 25 | GRK5 | 1.65789278 |
| 26 | PRKD3 | 1.61118148 |
| 27 | KSR1 | 1.59322453 |
| 28 | SIK2 | 1.55377542 |
| 29 | CDK5 | 1.53045421 |
| 30 | TNIK | 1.51003774 |
| 31 | FES | 1.50128371 |
| 32 | ARAF | 1.49910960 |
| 33 | MAP3K13 | 1.41545242 |
| 34 | CAMKK1 | 1.40753643 |
| 35 | RIPK1 | 1.33455916 |
| 36 | DAPK1 | 1.32092324 |
| 37 | STK38 | 1.29883269 |
| 38 | BMX | 1.29218184 |
| 39 | PRKCG | 1.26235833 |
| 40 | SIK1 | 1.24756893 |
| 41 | MAPK13 | 1.18008508 |
| 42 | CAMK2A | 1.16389566 |
| 43 | PIK3CA | 1.14689233 |
| 44 | TYRO3 | 1.08529100 |
| 45 | PRPF4B | 1.07966688 |
| 46 | BMPR2 | 1.07609092 |
| 47 | PTK2B | 1.05674452 |
| 48 | LATS2 | 1.04128016 |
| 49 | NME1 | 1.03821849 |
| 50 | TESK1 | 1.03405215 |
| 51 | CAMK2B | 1.02363057 |
| 52 | CDK19 | 1.00146277 |
| 53 | CAMK1G | 0.98690867 |
| 54 | MAP3K2 | 0.96146973 |
| 55 | UHMK1 | 0.94227654 |
| 56 | RAF1 | 0.90035221 |
| 57 | PHKG1 | 0.89954811 |
| 58 | PHKG2 | 0.89954811 |
| 59 | CDK14 | 0.88546446 |
| 60 | CDK18 | 0.87570034 |
| 61 | CDK15 | 0.86880723 |
| 62 | PAK3 | 0.86708300 |
| 63 | CAMK1 | 0.86093912 |
| 64 | DYRK1A | 0.80367565 |
| 65 | STK11 | 0.80087144 |
| 66 | FGR | 0.77065324 |
| 67 | CAMKK2 | 0.76736698 |
| 68 | CDK11A | 0.75282137 |
| 69 | TNK2 | 0.75148442 |
| 70 | OXSR1 | 0.72077624 |
| 71 | ILK | 0.71475636 |
| 72 | PRKCH | 0.71226849 |
| 73 | RET | 0.71130243 |
| 74 | CAMK2D | 0.70783094 |
| 75 | FER | 0.70750077 |
| 76 | MAPK4 | 0.68597485 |
| 77 | MAP3K6 | 0.67510081 |
| 78 | SGK494 | 0.66696795 |
| 79 | SGK223 | 0.66696795 |
| 80 | MAP2K3 | 0.66347253 |
| 81 | ROCK1 | 0.66219419 |
| 82 | SGK1 | 0.66066831 |
| 83 | LMTK2 | 0.65949410 |
| 84 | PRKG1 | 0.64305669 |
| 85 | MAP2K2 | 0.61867320 |
| 86 | PDK1 | 0.60335847 |
| 87 | EEF2K | 0.60144978 |
| 88 | PINK1 | 0.59623262 |
| 89 | PRKCE | 0.59221569 |
| 90 | ROCK2 | 0.59083420 |
| 91 | CSNK1G2 | 0.58768307 |
| 92 | PRKD1 | 0.58550628 |
| 93 | DDR2 | 0.58255958 |
| 94 | PDPK1 | 0.58241498 |
| 95 | MARK2 | 0.58210066 |
| 96 | EPHB1 | 0.57237136 |
| 97 | PDGFRA | 0.56199903 |
| 98 | MAP3K1 | 0.55013261 |
| 99 | MAP3K7 | 0.54548523 |
| 100 | GRK7 | 0.54355138 |
| 101 | MAPK7 | 0.54285620 |
| 102 | CAMK2G | 0.53026490 |
| 103 | PRKCZ | 0.53015702 |
| 104 | DMPK | 0.51972769 |
| 105 | PKN2 | 0.49390104 |
| 106 | FYN | 0.48496882 |
| 107 | CAMK4 | 0.47695606 |
| 108 | MAPK10 | 0.47655012 |
| 109 | RPS6KA3 | 0.45851052 |
| 110 | MOS | 0.45470776 |
| 111 | PDGFRB | 0.45468067 |
| 112 | WNK1 | 0.44583178 |
| 113 | DYRK1B | 0.44247494 |
| 114 | RPS6KA2 | 0.44111438 |
| 115 | PRKAA1 | 0.42668789 |
| 116 | MAP2K1 | 0.42354840 |
| 117 | SGK2 | 0.42326185 |
| 118 | DAPK3 | 0.42074394 |
| 119 | STK38L | 0.41533485 |
| 120 | TRPM7 | 0.41032550 |
| 121 | RPS6KB1 | 0.40775187 |
| 122 | ZAP70 | 0.40362234 |
| 123 | MAPKAPK5 | 0.39621046 |
| 124 | STK39 | 0.39580938 |
| 125 | ALK | 0.39172108 |
| 126 | EPHA3 | 0.38612056 |
| 127 | PRKAA2 | 0.37338116 |
| 128 | PKN1 | 0.37337166 |
| 129 | TAOK1 | 0.36914362 |
| 130 | LIMK1 | 0.36682536 |
| 131 | NEK6 | 0.35965352 |
| 132 | ABL2 | 0.35816367 |
| 133 | CDC42BPA | 0.35438394 |
| 134 | MAPK12 | 0.34792303 |
| 135 | MUSK | 0.34319875 |
| 136 | PRKACG | 0.34215153 |
| 137 | SGK3 | 0.34187721 |
| 138 | PRKACA | 0.32467736 |
| 139 | DYRK2 | 0.32241057 |
| 140 | SYK | 0.32217088 |
| 141 | PAK2 | 0.31816752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.13240754 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10061370 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84633747 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81549393 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.72688557 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60095093 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.59352072 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.49048878 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.35783231 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34093948 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.25489650 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23487572 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06976628 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 2.05455479 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.92215184 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88370629 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.83091388 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.80910454 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.79163593 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78669845 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72574655 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71806326 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66192844 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63434917 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60503044 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57230169 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43983032 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43866129 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.36485973 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36377386 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33898258 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.29420643 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27507362 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25546097 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23312610 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23288257 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14669334 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13805378 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.13548810 |
| 40 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.13451074 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.07841311 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07291341 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.05052419 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04766940 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04205594 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02051539 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.99552431 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98522131 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.97634543 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97103961 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96758080 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95850022 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93639345 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92530003 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91473639 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90147412 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86616918 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81659388 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81598047 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.80446789 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78662674 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78652924 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77608277 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77418268 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76780784 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75893700 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74675993 |
| 68 | Tight junction_Homo sapiens_hsa04530 | 0.73272060 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71690602 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70877871 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69121302 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67815721 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67479717 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66361078 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63832826 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.62584654 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61132357 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60770070 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59192908 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58890573 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56272490 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55286965 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55217962 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53391749 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53191325 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52937632 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52832876 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51064186 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50959785 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50834867 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50049866 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49801635 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49125990 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49019124 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48607233 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46820190 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46277981 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46093763 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.43944321 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43857204 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41988835 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41268964 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40984699 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40877078 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40626088 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39922834 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39799781 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39166696 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39086899 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.38405032 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38389371 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.37782803 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37590220 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36515681 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36421256 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36287276 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35759738 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.34841494 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30613613 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30074171 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29595327 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29022429 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.28822838 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27937442 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26641377 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25507426 |

